Arrowhead Pharmaceuticals, Inc.
$84.91
-3.68 (-4.15%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -2.8%
- 3 Months
- +9.0%
- YTD
- +27.9%
- 1 Year
- +289.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 63.7%
- Largest decline max drawdown, since Aug 2025
- -24.6%
- Risk-adjusted return Sharpe ratio, 1-year
- 2.45
Own ARWR?
See how ARWR contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.